BeStock  
Stocks › BEAM

Beam Therapeutics BEAM

US equityMarket cap rank #2581AI medical concept stocksGene Editing
$25.67 +$1.17 (+4.78%)
Pre-market · Oct 6, 7:30 am ET · After hours $25.55 -0.47%
Open$24.48
Prev close$24.50
Day range$23.83 – $26.04
Volume2.00M
Market cap$2.65B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-37.2x
CheapRich

Near the bottom of its 5-year range · 8th percentile, 5-year average -14.6x

Morningstar fair value estimate

Fair value$22.97
Price vs. fair value+11.8%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PE -37.20 -5.41 -14.60 8% (cheaper than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$22.97
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on BEAM.

Leave a comment

Scroll to Top